- Home
- CGON vs BKD Comparison
CGON vs BKD Comparison
Compare CGON & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- BKD
- Stock Information
- Founded
- CGON 2010
- BKD 2005
- Country
- CGON United States
- BKD United States
- Employees
- CGON N/A
- BKD N/A
- Industry
- CGON
- BKD Hospital/Nursing Management
- Sector
- CGON
- BKD Health Care
- Exchange
- CGON NYSE
- BKD Nasdaq
- Market Cap
- CGON 1.3B
- BKD 1.2B
- IPO Year
- CGON 2024
- BKD 2005
- Fundamental
- Price
- CGON $20.64
- BKD $6.24
- Analyst Decision
- CGON Strong Buy
- BKD Buy
- Analyst Count
- CGON 10
- BKD 5
- Target Price
- CGON $65.11
- BKD $7.50
- AVG Volume (30 Days)
- CGON 1.3M
- BKD 4.2M
- Earning Date
- CGON 05-08-2025
- BKD 05-06-2025
- Dividend Yield
- CGON N/A
- BKD N/A
- EPS Growth
- CGON N/A
- BKD N/A
- EPS
- CGON N/A
- BKD N/A
- Revenue
- CGON $1,139,000.00
- BKD $2,982,571,000.00
- Revenue This Year
- CGON N/A
- BKD $8.70
- Revenue Next Year
- CGON $16,237.24
- BKD N/A
- P/E Ratio
- CGON N/A
- BKD N/A
- Revenue Growth
- CGON 461.08
- BKD 4.02
- 52 Week Low
- CGON $14.80
- BKD $4.45
- 52 Week High
- CGON $46.99
- BKD $8.12
- Technical
- Relative Strength Index (RSI)
- CGON 43.38
- BKD 56.67
- Support Level
- CGON $19.47
- BKD $5.61
- Resistance Level
- CGON $20.63
- BKD $6.62
- Average True Range (ATR)
- CGON 2.07
- BKD 0.42
- MACD
- CGON 0.20
- BKD 0.03
- Stochastic Oscillator
- CGON 48.59
- BKD 76.97
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.